Skip to main content
OpenTrials
Completed

NCT Number: NCT04434287

Study of Prognostic Factors in Patients Admitted to ICU for Stroke

Outcome of stroke patients admitted to the intensive care unit the intensive care unit (ICU) is poor and haemorrhagic stroke, fixed dilated pupil(s) and GCS <10 are associated with increased mortality and poor functional outcome. However little is known about the impact of clinical events occuring during the ICU stay (ventilator acquired pneumoniae, shock, dysglycemia....).

The objective of this study was to determine the mortality rate and the functional outcomes of stroke patients admitted to ICU and to identify predictors of poor outcome in this population.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute stroke
  • ICU admission for acute stroke
  • 1 organ dysfunction : coma, shock, respiratory failure

Exclusion criteria

  • refuse participation

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: through ICU hospitalization, an average of one month

Secondary outcomes

  1. Mortality

    Time frame: At 90 days

    Mortality

  2. Functional outcome: Modified Rankin Score

    Time frame: at hospitalization discharge, an average of three months

    Modified Rankin Score (0: no symptoms at all; 6: dead)

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: REAVC

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 16, 2020
Registry last updated
Aug 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.